NCT03192488View on ClinicalTrials.gov

Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

June 6, 2018

Study Completion Date

June 6, 2018

Conditions
Hypoxia, Altitude
Interventions
DRUG

Cetirizine

Cetirizine tablet 10 mg

DRUG

Placebo oral capsule

Gelatin placebo

OTHER

Hypoxia

Exposure to a 14.3% oxygen environment simulating an altitude of 3,000m/9,000ft

Trial Locations (1)

47401

Indiana University, Bloomington

All Listed Sponsors
lead

Indiana University

OTHER

NCT03192488 - Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia | Biotech Hunter | Biotech Hunter